How to Check Whether a Medicine Is Registered by SAHPRA

Key takeaways

• A medicine is registered by the South African Health Products Regulatory Authority (SAHPRA) when the Authority has evaluated the application, is satisfied that the product meets the statutory requirements, issues a certificate of registration and allocates a registration number recorded against that medicine. “SAHPRA approved” is common shorthand, but the exact legal and practical question is whether the exact product is currently registered or supplied through a different lawful route.
• Verify the product name, active ingredient, strength, dosage form, holder of the certificate of registration and registration number against SAHPRA’s current registers and approved product information. Registration does not attach to an ingredient, seller, manufacturer, brand family or foreign approval in the abstract. A different strength, dosage form, formulation, applicant or presentation may have a different status.
• Do not treat a pending application, Section 21 authorisation, approved clinical trial, patient-specific compounded preparation or licensed manufacturer as proof that the product itself is registered. Each is a separate regulatory concept. If the official records and the package do not match, preserve the evidence and ask SAHPRA or a registered pharmacist to verify the status before making an accusation or relying on the seller’s claim.
• This guide is checked to 22 July 2026. It owns the general consumer product-registration verification question. The separate compounded-semaglutide article owns the product-specific compounding, prescriber, pharmacy and complaint analysis.

Registration belongs to the exact product

Section 15 of the Medicines and Related Substances Act provides for an application to be evaluated. If SAHPRA is satisfied that the medicine is suitable for its intended purpose, meets prescribed requirements, and is safe, efficacious and of good quality, the Authority issues a certificate of registration. The Chief Executive Officer allocates the registration number and records it in the register.

That decision concerns defined product particulars. For a consumer check, record:

• the complete proprietary or product name;
• every active ingredient and stated quantity;
• strength and dosage form, such as tablet, capsule, solution or injection;
• pack size and presentation;
• the holder of the certificate of registration or marketing-authorisation holder;
• the printed registration or application number;
• manufacturer, importer, distributor and dispensing pharmacy where shown;
• batch or lot number and expiry date; and
• the claimed indication and schedule.

Do not conclude that two products share registration merely because their active ingredient sounds the same. A registered tablet does not prove the status of an injection, powder, compounded vial or different strength. A genuine registration number copied onto a different product also does not make that product registered.

Use more than one current SAHPRA record

SAHPRA provides several public tools because they answer related but different questions:

1. Registered Health Products list: use this to check whether the product appears in the regulator’s registered-product records.
2. Medicines Online Directory: search by the exact product name and, where useful, the active ingredient. SAHPRA’s April 2026 toolkit describes the directory as a trusted consumer and professional source and records its expansion from over-the-counter to prescription medicines.
3. PI and PIL Repository: compare the Professional Information and Patient Information Leaflet entry, including product, holder, dosage form, strength and approval date where published.
4. Active Pharma Licenced Establishments: check the relevant manufacturer, importer, wholesaler or distributor separately. This answers an establishment-licence question, not product registration.
5. Rapid Alert System and recall notices: check whether SAHPRA has published a current quality alert, falsification warning, recall or other affected-product notice.

Search spelling variants carefully and retain a dated record of what you searched. A public database may be updated, may separate over-the-counter and prescription material, or may not expose every historical record in the same way. A missing result is a reason to request confirmation; it is not enough by itself to declare a product illegal, counterfeit or unsafe.

Match the package to the official particulars

The General Regulations prescribe medicine-labelling particulars, and SAHPRA publishes current labelling and patient-information guidance. Compare all available surfaces—the outer carton, immediate container, blister, vial, leaflet and dispensing label—rather than relying on the front brand name.

Look for:

• a registration number or, where a different status is claimed, the exact application or authorisation reference;
• consistent product name, active ingredient, strength and dosage form;
• the same certificate holder or marketing-authorisation holder as the official record;
• batch number, expiry date, storage conditions and pack integrity;
• approved Professional Information or Patient Information Leaflet that corresponds to the product;
• a legitimate supplier and traceable dispensing record; and
• corrections, stickers, over-labelling or language that obscure or contradict the original particulars.

A polished package, QR code, “doctor recommended” statement, pharmacy-style label or reference to “international approval” is not a substitute for the South African registration record. Likewise, registration does not establish that a medicine is appropriate for a particular person, diagnosis, dose or combination. Those are clinical questions for an authorised healthcare professional.

The consumer complaint checklist can organise the product, transaction, representation and correspondence records without deciding regulatory status.

“Approved” can describe a different regulatory decision

Ask the seller or practitioner to name the precise route instead of accepting the word “approved”.

Pending registration application

An application number or “in review” status means an application is being considered. It is not a certificate of registration. Section 15 expressly separates receipt and consideration of an application from the later decision to register or reject it.

Section 21 access

Section 21 allows SAHPRA to authorise a specified quantity of an unregistered medicine for a specified person or institution, period, purpose and conditions. SAHPRA’s current guideline and application portal describe access to an unregistered medicine. The authorisation is not general product registration and should be checked against the patient, practitioner, quantity, validity period and conditions in the actual approval.

Clinical-trial approval

SAHPRA can authorise a clinical trial involving a registered or unregistered medicine. Approval to conduct the trial is not permission to market the investigational product to the general public and is not proof that the product has been registered. Trial participation should be verified through the study documents, investigator, ethics approval and SAHPRA-authorised protocol—not an ordinary sales page.

Patient-specific compounding

Section 14(4) and the Regulations create a narrow framework for certain patient-specific compounded medicines. A compounded preparation is not automatically SAHPRA-registered merely because it uses an active component found in a registered medicine. Product-specific compounding questions require the prescription, patient label, authorised professional, pharmacy, quantity, source and advertising facts.

Establishment licensing

A section 22C licence may authorise a manufacturer, importer, wholesaler or distributor to conduct specified activities subject to conditions. It does not register every product handled by that establishment. Check the product record and the establishment record separately.

Approval by a foreign regulator

Registration or emergency authorisation in another country may be relevant to SAHPRA’s evaluation or a special-access decision, but it is not itself South African registration. Ask for the SAHPRA record or the exact South African authorisation relied upon.

Interpret the result without overclaiming

Use a neutral status note:

• Exact match found: record the official source, date, product name, strength, dosage form, holder and registration number. Then check alerts and the actual pack.
• Near match only: record every mismatch. Do not substitute an ingredient, brand, strength or dosage form for the offered product.
• Section 21 claimed: request the current approval and verify the named practitioner, patient or institution, product, quantity, period and conditions.
• Compounding claimed: do not search for a registration number as though it were a mass-market product; verify the separate patient-specific conditions.
• No match found: repeat the search, check the available SAHPRA repositories, ask a registered pharmacist and seek written regulator confirmation where needed.
• Alert or recall found: follow the exact affected-product, batch and return or safety instructions in the notice. Do not assume every product with a similar name is included.

The product-recall glossary distinguishes a batch-specific recall from a general product-status question. The consumer-protection glossary and consumer-rights resources provide wider transaction and complaint context.

Preserve evidence before contacting the supplier or regulator

Keep:

1. clear photographs of every package face, container, seal and leaflet;
2. the registration, application, Section 21 or other number exactly as shown;
3. batch or lot number, expiry date and storage instructions;
4. prescription, dispensing label and pharmacy details where applicable;
5. invoice, receipt, payment record, delivery note and courier information;
6. the seller’s page, advertisement and claims about SAHPRA, safety, efficacy or “generic” status;
7. emails, messages, call notes and the names or roles used by each person;
8. dated screenshots or exports from the official SAHPRA tools; and
9. any adverse-event, product-quality, refund or return record.

Keep the product and packaging safely unless a healthcare professional, pharmacy, regulator or recall notice directs otherwise. Do not open, inject, taste or use a suspect product merely to create evidence. Do not publish a person’s health information, prescription or unsupported allegation online.

If there is an immediate health concern, seek appropriate medical assistance and use SAHPRA’s adverse-event or product-quality reporting route. Do not start, stop, replace or change a prescribed medicine based only on this article or a database search.

Route the question to the body that can answer it

Contact SAHPRA for confirmation of registration, Section 21 status, suspected unregistered or falsified products, product-quality concerns, recalls and adverse-event reporting. Contact the South African Pharmacy Council to verify a pharmacy or pharmacist and for pharmacy-practice complaints. A supplier refund or marketing dispute may also require the supplier’s process and an appropriate consumer route.

For material injury, significant loss, cross-border supply, regulatory enforcement, a contested product-status representation or multi-party responsibility, define a focused legal mandate. Ask the practitioner to identify:

1. the exact product and claimed route;
2. current registration, authorisation and licence evidence;
3. any package or official-record mismatch;
4. the seller, certificate holder, manufacturer, importer, distributor, prescriber and pharmacy;
5. the applicable regulator and complaint or enforcement route;
6. evidence needed for causation, loss, refund or other remedy; and
7. scope, fees, urgency and the next decision point.

Use the lawyer directory or law-firms directory to discover providers. Verify practising status through the Legal Practice Council and ask for relevant medicines-regulation, health-law, consumer or product-liability experience.

Source and review note

This is general legal and regulatory information, not a product-status ruling or medical advice. Source review covered sections 14 to 18, 21 and 22C of the Medicines Act; the General Regulations; SAHPRA’s current product registers, Online Medicines Directory and PI/PIL repository; current Section 21 guidance; clinical-trial material; establishment-licence lists; rapid alerts; and professional verification routes. Registration, continued-right-of-sale records, application status, special access, compounding, trials, licensing, labelling, advertising, importation, recalls, falsification, adverse events, professional conduct, consumer remedies, causation and treatment decisions remain product-, route-, record-, date-, person- and fact-specific. A qualified South African medicines-regulatory and source/legal reviewer must verify the exact product and current official records before publication or reliance.

Authoritative sources used:

• Medicines and Related Substances Act 101 of 1965, as amended, especially sections 14 to 18, 21 and 22C.
• General Regulations under the Medicines Act, for registration, labelling, patient information, special-access, trial and vigilance requirements.
• SAHPRA E-Services, for current Registered Health Products, Section 21, directory and reporting tools.
• Medicines Online Directory Toolkit—OTC and prescription, for the April 2026 directory scope and consumer-verification purpose.
• SAHPRA PI and PIL Repository, for product, holder, dosage-form, strength and approved-information comparison.
• Guideline for Section 21 Access to Unregistered Medicines, version 6 dated 30 October 2025, for the controlled unregistered-medicine route.
• Clinical Trial Participant TIE Compensation Model, current version dated 27 March 2026, confirming that authorised trials may use registered or unregistered medicines.
• Active Pharma Licenced Establishments, for the separate establishment-licence check.
• SAHPRA Rapid Alert System, for current quality and falsification alerts.
• South African Pharmacy Council public portal, for pharmacy and pharmacist verification and complaint routes.
• Legal Practice Council practitioner search, for practising-status verification.

FAQs

Related Lexuno paths